The UKRI Future Leader Fellowships aim to grow the strong supply of talented individuals needed to ensure a vibrant environment for research and innovation in the UK. The scheme is open to early career researchers and innovators from across business, universities, and other organisations and from around the world.
We are still awaiting confirmation from UKRI that Round 8 of the call will go ahead (expected deadline July 2023). Once confirmed we will announce the BU internal process to ensure we support and encourage submissions from the highest standard of candidates. For the next round we are expecting to select a maximum of 3 applications to progress to submission.
The internal process is likely to have a short turnaround time and so we suggest if you are interested in applying to this scheme you start to work on your ideas with your mentor as soon as you can. The internal process documents for the last round are still available at I:\RDS\Public\FLF Round 7 Dec 2022 and we have lots of guidance to support you available on Brightspace, specifically on the UKRI Future Leader Fellowships, and preparing a Fellowship application in general.
The Funding Development Briefing on Weds 16th November at 12 midday will also cover this call. If you are interested in hearing more, please come along to the session by clicking here or contact Lisa Andrews, Research Facilitator, RDS.
UKRI Future Leader Fellowships Round 7 – Internal Process Launched
UKRI Future Leader Fellowships Round 6 – Internal Process Launched
Funding Development Briefing 16/11/22 Spotlight on: UKRI Future Leader Fellowships










Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease